|
|
|
Company Name
|
VIVUS INC
|
|
Drug Name
|
Qnexa (NDA resubmission)
|
|
Event Name
|
FDA decision on Qnexa as proposed treatment for obesity
|
|
Event Date
|
07/17/2012
|
|
Outcome
|
FDA approved Qsymia, formerly known as Qnexa, for obesity
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|